What is CDRD?
The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
Latest from the Blog
+ Closing the Gender Gap in Science, Technology, Mathematics and Engineering (STEM)
+ CDRD Chemistry Makes for a Unique Co-Op Experience
+ VISIT THE BLOG
News & Publications
-
- June 10, 2013 CDRD Scientists Contribute to Publication on Potential Colorectal Cancer Treatment Using Irinophore C and 5-Fluorouracil
- June 6, 2013 CDRD Medicinal Chemistry Division Co-Authors Publication on hypoxia-activated inhibitor of DNA-PK
-
- February 28, 2011 In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer
- November 3, 2011 The Solid-State Characterization of Fusidic Acid
- November 29, 2011 A Quantitative Method for the Specific Assessment of Caspase-6 Activity in Cell Culture
- March 2, 2012 Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles
A Shared Vision
-
-
-
- Industry
- Academia
- Government
